Approval · Notice of Compliance 28894 · 2022
MONOFERRIC: Notice of Compliance 28894
Issued September 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28894
- Date
- September 2, 2022
- Company
- Pharmacosmos AHolbaek, --, Denmark
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new drug product manufacturing and testing site.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MONOFERRIC | Not yet assigned | — |
Medicinal ingredients
- FERRIC DERISOMALTOSE 100 MG per ML